These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7744601)
1. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines. Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601 [TBL] [Abstract][Full Text] [Related]
2. Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Gorodetsky R; Levy-Agababa F; Mou X; Vexler AM Int J Cancer; 1998 Feb; 75(4):635-42. PubMed ID: 9466668 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Raaphorst GP; Miao J; Ng CE Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189 [TBL] [Abstract][Full Text] [Related]
4. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696 [TBL] [Abstract][Full Text] [Related]
6. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line. Siler DF; Wheeless CR; Dubin NH Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684 [TBL] [Abstract][Full Text] [Related]
7. Effect of combined treatment with radiation and low dose etoposide on cell survival. Shigematsu N; Kawata T; Ihara N; Kawaguchi O; Kutsuki S; Ishibashi R; Kubo A; Ito H Anticancer Res; 2001; 21(1A):325-8. PubMed ID: 11299757 [TBL] [Abstract][Full Text] [Related]
8. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333 [TBL] [Abstract][Full Text] [Related]
9. Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation. De Pooter CM; Scalliet PG; Elst HJ; Huybrechts JJ; Gheuens EE; Van Oosterom AT; Fichtinger-Schepman AM; De Bruijn EA Cancer Res; 1991 Sep; 51(17):4523-7. PubMed ID: 1873796 [TBL] [Abstract][Full Text] [Related]
10. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin. Caney C; Singh G; Lukka H; Rainbow AJ Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706 [TBL] [Abstract][Full Text] [Related]
11. Radiosensitivity patterns of four human ovarian cancer cell lines in vitro. Petru E; Sevin BU; Gottlieb C Gynecol Oncol; 1997 Mar; 64(3):490-2. PubMed ID: 9062157 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model. Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108 [TBL] [Abstract][Full Text] [Related]
13. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin. Overgaard J; Khan AR Cancer Treat Rep; 1981; 65(5-6):501-3. PubMed ID: 7195305 [TBL] [Abstract][Full Text] [Related]
14. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R; Tanabe K; Inoue H; Toge T Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567 [TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor PS-341 in cancer therapy. Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643 [TBL] [Abstract][Full Text] [Related]
16. Application of the ATP-cell viability assay for assessment of in vitro radiation treatment response in gynecologic cancer cell lines. Rodriguez M; Steren AJ Contrib Gynecol Obstet; 1994; 19():156-65. PubMed ID: 7995047 [No Abstract] [Full Text] [Related]
17. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology. Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906 [TBL] [Abstract][Full Text] [Related]
18. C6 cells cross-resistant to cisplatin and radiation. Poppenborg H; Münstermann G; Knüpfer MM; Hotfilder M; Wolff JE Anticancer Res; 1997; 17(3C):2073-7. PubMed ID: 9216666 [TBL] [Abstract][Full Text] [Related]
19. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay. Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096 [TBL] [Abstract][Full Text] [Related]
20. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]